WallStreetZenWallStreetZen

NASDAQ: ABVX
Abivax Sa Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ABVX past revenue growth

How has ABVX's revenue growth performed historically?
Company
5.31%
Industry
144.63%
Market
17.55%
ABVX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ABVX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ABVX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ABVX earnings and revenue history

Current Revenue
$5.1M
Current Earnings
-$164.2M
Current Profit Margin
-3,197.1%

ABVX Return on Equity

Current Company
-145.4%
Current Industry
-63.5%
Current Market
188.7%
ABVX's Return on Equity (-145.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ABVX announces earnings.

ABVX Return on Assets

Current Company
-73.4%
Current Industry
2.9%
ABVX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ABVX Return on Capital Employed

Current Company
-46.64%
Current Industry
19.5%

ABVX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ABVX$5.02M-$129.52M-$160.59M-38.54%N/A
BCYC$26.98M-$169.40M-$180.66M+30.47%N/A
SAVA$0.00-$95.69M-$97.22MN/AN/A
INVA$310.46M$248.96M$179.72M+3.53%-6.84%
LQDA$17.49M-$69.65M-$78.50M+45.23%N/A
View Top Biotech Stocks

Abivax Sa Earnings & Revenue FAQ

What were ABVX's earnings last quarter?

On Invalid Date, Abivax Sa (NASDAQ: ABVX) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Abivax Sa earnings for the quarter were N/A. In the same quarter last year, Abivax Sa's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Abivax Sa stock.

What was ABVX's earnings growth in the past year?

As of Q2 2024, Abivax Sa's earnings has grown year over year. Abivax Sa's earnings in the past year totalled -$160.59 million.

What was ABVX's revenue last quarter?

On Invalid Date, Abivax Sa (NASDAQ: ABVX) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Abivax Sa's revenue was N/A.

What was ABVX's revenue growth in the past year?

As of Q2 2024, Abivax Sa's revenue has grown 5.31% year over year. This is 139.32 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Abivax Sa's revenue in the past year totalled $5.02 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.